GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aspen Pharmacare Holdings APN.JO · ZAc

Health Care · JSE · 🇿🇦 South Africa

Compare

16,886.00

+1.48%

Close of 9 Nov 2026, in ZAc

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in ZAR, from our data supplier.

FY2026

Revenue

ZAR 34.87bn

FY2017FY2026

Net income

ZAR 2.65bn

FY2017FY2026

Free cash flow

ZAR 4.73bn

FY2017FY2026

Shareholders' equity

ZAR 80.37bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueZAR 34.87bnZAR 43.36bnZAR 44.71bnZAR 40.71bnZAR 38.61bnZAR 37.77bnZAR 38.65bnZAR 38.87bnZAR 42.60bnZAR 41.20bn
Gross profitZAR 14.05bnZAR 19.13bnZAR 19.42bnZAR 18.41bnZAR 18.31bnZAR 17.79bnZAR 19.33bnZAR 19.70bnZAR 21.61bnZAR 19.90bn
Research and development——ZAR 162.0mZAR 214.0mZAR 433.0mZAR 260.0mZAR 195.0mZAR 211.0mZAR 3.0mZAR 188.0m
Operating incomeZAR 5.40bnZAR 1.44bnZAR 7.00bnZAR 7.82bnZAR 8.67bnZAR 7.07bnZAR 7.06bnZAR 4.81bnZAR 9.24bnZAR 8.30bn
Net incomeZAR 2.65bn−ZAR 1.08bnZAR 4.40bnZAR 5.23bnZAR 6.49bnZAR 4.81bnZAR 4.66bnZAR 6.46bnZAR 6.01bnZAR 5.10bn
Diluted earnings per share5.97-2.449.9211.7714.6110.5310.2214.1613.1711.17

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsZAR 108.27bnZAR 135.89bnZAR 139.16bnZAR 134.28bnZAR 111.38bnZAR 109.68bnZAR 133.17bnZAR 122.32bnZAR 132.84bnZAR 116.30bn
Cash and short-term investmentsZAR 16.00bnZAR 6.41bnZAR 12.34bnZAR 10.91bnZAR 6.18bnZAR 8.55bnZAR 7.09bnZAR 8.98bnZAR 11.17bnZAR 10.70bn
Total liabilitiesZAR 27.90bnZAR 51.00bnZAR 54.29bnZAR 48.05bnZAR 40.43bnZAR 44.06bnZAR 63.95bnZAR 68.10bnZAR 82.74bnZAR 73.20bn
DebtZAR 15.57bnZAR 36.12bnZAR 36.46bnZAR 29.28bnZAR 22.25bnZAR 24.87bnZAR 42.32bnZAR 47.96bnZAR 57.95bnZAR 47.88bn
Shareholders' equityZAR 80.37bnZAR 84.89bnZAR 84.86bnZAR 86.24bnZAR 70.94bnZAR 65.63bnZAR 69.22bnZAR 54.21bnZAR 50.07bnZAR 43.10bn
Shares outstanding443m445m444m444m444m457m457m457m456m456m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsZAR 6.87bnZAR 5.16bnZAR 6.22bnZAR 5.52bnZAR 5.37bnZAR 6.83bnZAR 8.26bnZAR 6.00bnZAR 7.02bnZAR 6.50bn
Capital spending−ZAR 2.14bn−ZAR 5.05bn−ZAR 5.54bn−ZAR 3.18bn−ZAR 2.70bn−ZAR 3.43bn−ZAR 2.69bn−ZAR 3.58bn−ZAR 8.23bn−ZAR 2.60bn
Free cash flowZAR 4.73bnZAR 104.0mZAR 690.0mZAR 2.34bnZAR 2.68bnZAR 3.39bnZAR 5.57bnZAR 2.42bn−ZAR 1.21bnZAR 3.90bn
Dividends paid−ZAR 941.0m−ZAR 1.60bn−ZAR 1.52bn−ZAR 1.46bn−ZAR 1.20bn−ZAR 1.20bn−ZAR 1.20bn−ZAR 1.44bn−ZAR 1.31bn−ZAR 1.20bn

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023
RevenueZAR 17.79bnZAR 17.08bnZAR 21.40bnZAR 21.96bnZAR 23.57bnZAR 21.14bnZAR 10.57bnZAR 21.56bn
Gross profitZAR 6.60bnZAR 7.45bnZAR 8.68bnZAR 10.45bnZAR 10.10bnZAR 9.31bnZAR 4.66bnZAR 9.97bn
Operating incomeZAR 2.29bnZAR 3.11bnZAR 3.05bnZAR 5.08bnZAR 3.50bnZAR 3.50bnZAR 1.75bnZAR 5.16bn
Net incomeZAR 1.18bnZAR 1.47bn−ZAR 3.47bnZAR 2.39bnZAR 2.09bnZAR 2.31bnZAR 1.16bnZAR 2.55bn
Diluted earnings per share2.653.31-7.815.384.715.212.605.75
Cash from operationsZAR 3.29bnZAR 3.58bnZAR 3.35bnZAR 1.80bnZAR 3.77bnZAR 2.46bnZAR 1.23bnZAR 3.81bn
Capital spending−ZAR 1.01bn−ZAR 1.13bn−ZAR 1.38bn−ZAR 1.20bn−ZAR 1.63bn−ZAR 1.49bn−ZAR 746.0m−ZAR 2.06bn
Free cash flowZAR 2.28bnZAR 2.45bnZAR 1.98bnZAR 608.0mZAR 2.14bnZAR 966.0mZAR 483.0mZAR 1.75bn
Total assetsZAR 108.27bnZAR 128.04bnZAR 135.89bnZAR 136.60bnZAR 139.16bnZAR 139.29bnZAR 139.29bnZAR 134.28bn
Cash and short-term investmentsZAR 16.00bnZAR 5.62bnZAR 6.41bnZAR 6.80bnZAR 12.34bnZAR 11.60bnZAR 11.60bnZAR 10.91bn
DebtZAR 6.07bnZAR 32.94bnZAR 36.12bnZAR 35.47bnZAR 36.13bnZAR 36.12bnZAR 11.60bnZAR 29.28bn
Shareholders' equityZAR 80.37bnZAR 81.09bnZAR 84.89bnZAR 85.09bnZAR 84.86bnZAR 85.60bnZAR 85.60bnZAR 86.24bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.0%-1.6%-0.2%
Operating income-11.6%-5.3%-5.0%
Net income-20.3%-11.2%-4.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.4%43.4%44.6%47.0%
Operating margin8.7%13.2%15.6%17.3%
Net margin2.0%6.8%9.4%11.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings27.6-48.016.617.39.321.312.38.410.224.8
Price to sales2.11.21.62.21.62.71.51.41.43.1

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 1 Oct 2025.

FY2026FY2025FY2024FY2023FY2022FY2019FY2018FY2017
Paid in the year2.113.793.423.262.623.152.872.48
  • 1.017-for-1 split · 6 Oct 2008
  • 1-to-1 reverse split · 27 Jun 2005
  • 1-to-1 reverse split · 1 Feb 1999
  • 2-to-1 reverse split · 21 Nov 1994

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.